Reduced Likelihood of Hospitalization with the JN.1 or HV.1 SARS-CoV-2 Variants Compared to the EG.5 Variant.

Reduced Likelihood of Hospitalization with the JN.1 or HV.1 SARS-CoV-2 Variants Compared to the EG.5 Variant.

Publication date: Jul 19, 2024

Within a multi-state viral genomic surveillance program, we evaluated whether proportions of SARS-CoV-2 infections attributed to the JN. 1 variant and to XBB-lineage variants (including HV. 1 and EG. 5) differed between inpatient and outpatient care settings during periods of cocirculation. Both JN. 1 and HV. 1 were less likely than EG. 5 to account for infections among inpatients versus outpatients (aOR=0. 60 [95% CI: 0. 43-0. 84; p=0. 003] and aOR=0. 35 [95% CI: 0. 21-0. 58; p

Concepts Keywords
Genomic COVID-19
Outpatients genomic surveillance
Surveillance hospitalization
Viral SARS-CoV-2 variants
severity

Semantics

Type Source Name
disease MESH SARS-CoV-2 infections
disease MESH infections

Original Article

(Visited 1 times, 1 visits today)